SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000769993-15-000365
Filing Date
2015-02-17
Accepted
2015-02-17 17:20:04
Documents
1
Group Members
BRIDGE STREET 2013 HOLDINGS, L.P.BRIDGE STREET OPPORTUNITY ADVISORS, L.L.C.BROAD STREET PRINCIPAL INVESTMENTS, L.L.C.GOLDMAN, SACHS & CO.MBD 2013 HOLDINGS, L.P.MBD ADVISORS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 t2biosystemsinc0gsco.txt SC 13G 46892
  Complete submission text file 0000769993-15-000365.txt   48791
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 2129021000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

IRS No.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Subject) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88541 | Film No.: 15624407
SIC: 3841 Surgical & Medical Instruments & Apparatus